- Home
- PRTA vs CPS Comparison
PRTA vs CPS Comparison
Compare PRTA & CPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- CPS
- Stock Information
- Founded
- PRTA 2012
- CPS 1960
- Country
- PRTA Ireland
- CPS United States
- Employees
- PRTA N/A
- CPS N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- CPS Auto Parts:O.E.M.
- Sector
- PRTA Health Care
- CPS Consumer Discretionary
- Exchange
- PRTA Nasdaq
- CPS Nasdaq
- Market Cap
- PRTA 472.1M
- CPS 462.2M
- IPO Year
- PRTA N/A
- CPS N/A
- Fundamental
- Price
- PRTA $8.16
- CPS $39.04
- Analyst Decision
- PRTA Buy
- CPS Hold
- Analyst Count
- PRTA 10
- CPS 1
- Target Price
- PRTA $12.29
- CPS $12.00
- AVG Volume (30 Days)
- PRTA 935.9K
- CPS 227.6K
- Earning Date
- PRTA 11-11-2025
- CPS 10-30-2025
- Dividend Yield
- PRTA N/A
- CPS N/A
- EPS Growth
- PRTA N/A
- CPS N/A
- EPS
- PRTA N/A
- CPS 1.65
- Revenue
- PRTA $10,341,000.00
- CPS $2,719,148,000.00
- Revenue This Year
- PRTA N/A
- CPS $2.46
- Revenue Next Year
- PRTA $389.77
- CPS $3.29
- P/E Ratio
- PRTA N/A
- CPS $23.46
- Revenue Growth
- PRTA N/A
- CPS N/A
- 52 Week Low
- PRTA $4.32
- CPS $10.38
- 52 Week High
- PRTA $22.71
- CPS $39.79
- Technical
- Relative Strength Index (RSI)
- PRTA 51.80
- CPS 74.19
- Support Level
- PRTA $8.19
- CPS $37.24
- Resistance Level
- PRTA $8.50
- CPS $39.67
- Average True Range (ATR)
- PRTA 0.33
- CPS 1.54
- MACD
- PRTA -0.09
- CPS -0.17
- Stochastic Oscillator
- PRTA 16.18
- CPS 87.02
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About CPS Cooper-Standard Holdings Inc.
Cooper-Standard Holdings Inc is engaged in the manufacture of sealing and fluid handling systems (consisting of fuel and brake delivery systems and fluid transfer systems). Its products are designed for passenger vehicles and light trucks that are manufactured by automotive original equipment manufacturers (OEMs) and replacement markets. It has two reportable segments: Sealing Systems and Fluid Handling Systems. The group's geographic regions are North America, Europe, Asia Pacific, and South America.